Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Vor Biopharma Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −16 vs. Q2 2024
- Shares held
- 47.8M
- −6.20M (−11.5%) vs. Q2 2024
- Total value
- $33.5M
- −$20.6M (−38.0%) vs. Q2 2024
- New holders
- 10
- 8 more added
- Sold out
- 26
- 19 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 22,748,880 | $15.9M | 0.18% | 00.0% | Unchanged |
| FMR LLC | 7,071,110 | $4.95M | 0.00% | −4,692−0.1% | Reduced |
| 5AM Venture Management, LLC | 6,361,723 | $4.45M | 0.92% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 2,466,236 | $1.73M | 0.01% | +2,466,236 | New |
| Vanguard Group Inc | 1,954,285 | $1.37M | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 1,220,590 | $854.4K | 0.03% | +1,220,590 | New |
| Johnson & Johnson | 1,074,658 | $752.3K | 0.18% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 756,011 | $529.2K | 0.00% | +260,711+52.6% | Added |
| Sarissa Capital Management LP | 618,000 | $432.6K | 0.11% | 00.0% | Unchanged |
| BlackRock, Inc. | 487,654 | $341.4K | 0.00% | +487,654 | New |
| MAI Capital Management | 475,891 | $333.1K | 0.00% | +5,823+1.2% | Added |
| Geode Capital Management, LLC | 422,143 | $295.6K | 0.00% | −2,689−0.6% | Reduced |
| Ensign Peak Advisors, Inc | 329,378 | $230.6K | 0.00% | −16,709−4.8% | Reduced |
| Millennium Management LLC | 303,825 | $212.7K | 0.00% | −85,813−22.0% | Reduced |
| Exchange Traded Concepts, LLC | 165,805 | $116.1K | 0.00% | +48,017+40.8% | Added |
| Two Sigma Investments, LP | 137,134 | $96.0K | 0.00% | +137,134 | New |
| Bridgeway Capital Management, LLC | 135,900 | $95.1K | 0.00% | −30,000−18.1% | Reduced |
| Marshall Wace, LLP | 116,635 | $81.6K | 0.00% | +35,521+43.8% | Added |
| State Street Corp | 115,934 | $81.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 113,365 | $79.4K | 0.00% | −267,378−70.2% | Reduced |
| Acadian Asset Management LLC | 81,305 | $55.0K | 0.00% | 00.0% | Unchanged |
| Rosalind Advisors, Inc. | 76,685 | $53.7K | 0.04% | +76,685 | New |
| Bollard Group LLC | 55,555 | $39.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 51,111 | $35.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 50,300 | $35.2K | 0.00% | +50,300 | New |
| HSBC Holdings PLC | 44,728 | $32.5K | 0.00% | −4,310−8.8% | Reduced |
| Nomura Holdings Inc | 41,495 | $29.0K | 0.00% | +41,495 | New |
| Qube Research & Technologies Ltd | 30,825 | $21.6K | 0.00% | −64,542−67.7% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 29,530 | $20.7K | 0.00% | −33,732−53.3% | Reduced |
| Laurion Capital Management LP | 28,981 | $20.3K | 0.00% | −2,496,468−98.9% | Reduced |
| Goldman Sachs Group Inc | 28,227 | $19.8K | 0.00% | −347,115−92.5% | Reduced |
| Ground Swell Capital, LLC | 26,103 | $18.3K | 0.03% | +5,429+26.3% | Added |
| Money Concepts Capital Corp | 25,000 | $17.5K | 0.00% | +5,000+25.0% | Added |
| Morgan Stanley | 24,448 | $17.1K | 0.00% | −144,852−85.6% | Reduced |
| Dimensional Fund Advisors LP | 24,219 | $17.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,792 | $12.5K | 0.00% | 00.0% | Unchanged |
| United Bank | 15,300 | $10.7K | 0.00% | 00.0% | Unchanged |
| Grimes & Company, Inc. | 15,142 | $10.6K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 13,761 | $9.63K | 0.00% | −208,740−93.8% | Reduced |
| Chicago Partners Investment Group LLC | 13,593 | $9.55K | 0.00% | −2,880−17.5% | Reduced |
| JPMorgan Chase & Co | 12,038 | $8.43K | 0.00% | +11,055+1,124.6% | Added |
| Barclays PLC | 11,024 | $7.72K | 0.00% | −14,727−57.2% | Reduced |
| Chiron Capital Management, LLC | 11,000 | $7.70K | 0.01% | +11,000 | New |
| Catalyst Funds Management Pty Ltd | 9,800 | $6.86K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,871 | $4.11K | 0.00% | −19,294−76.7% | Reduced |
| Tower Research Capital LLC (TRC) | 4,298 | $3.01K | 0.00% | −11,312−72.5% | Reduced |
| Simplex Trading, LLC | 5,053 | $3.00K | 0.00% | +5,053 | New |
| Federated Hermes, Inc. | 3,759 | $2.63K | 0.00% | +159+4.4% | Added |
| Citadel Advisors LLC | 713 | $499 | 0.00% | −83,932−99.2% | Reduced |
| SRS Capital Advisors, Inc. | 528 | $370 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 200 | $140 | 0.00% | 00.0% | Unchanged |
| Eagle Bay Advisors LLC | 150 | $105 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 26 | $18 | 0.00% | −14,376−99.8% | Reduced |
| Royal Bank of Canada | 55 | $0 | 0.00% | +55 | New |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −6,457,293−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −247,167−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −132,298−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −77,800−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −52,914−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −52,287−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −35,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −31,855−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −22,488−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −19,524−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −17,596−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,370−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,328−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,204−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11,201−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −6,456−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −5,505−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −5,111−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,945−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,231−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −322−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |